Unraveling the HER2-Low Breast Cancer Puzzle – Treatment Sequencing and Targeted Therapies
In this MEDtalk, Hematologist Arya Mariam Roy from the Roswell Park Comprehensive Cancer Center in New York presents a review of treatment options in HER2-low breast cancer and discusses treatment sequencing algorithms.
